Design Therapeutics Secures $125 Million in Series B Financing to Advance Pipeline of Genomic Medicines for Nucleotide Repeat Expansion Disorders

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3adZ8lk
via IFTTT